Moximed
-
Sports Medicine
Moximed Raises $40 Million to Advance World’s First Implantable Shock Absorber for Knee Osteoarthritis
August 16, 2022 FREMONT, Calif.–(BUSINESS WIRE)–Moximed, a medical device company on a mission to improve the standard of care for…
Read More » -
Financial
Moximed Closes Oversubscribed $50MM Financing Round
News Release – March 16, 2017 HAYWARD, Calif.–(Healthcare Sales & Marketing Network)–Moximed®, Inc., developer of unicompartmental load absorber implants for…
Read More » -
Sports Medicine
Moximed: First Patient Treated in US Study of Atlas® System for Unicompartmental Knee Osteoarthritis
November 29, 2016 HAYWARD, Calif.–(BUSINESS WIRE)–Moximed®, Inc. announced today that the first patient has been treated in an FDA-approved IDE…
Read More » -
Recon
Cost Effectiveness and Economic Impact of the KineSpring® Knee Implant System in the Treatment of Knee Osteoarthritis in Spain.
Strain D, et al. J Long Term Eff Med Implants. 2015. Show full citation Abstract We investigated the efficacy and…
Read More » -
Recon
Atlas, an Implantable Shock Absorber for Your Knee
Moximed, a firm with offices in Hayward, California and Zurich, Switzerland, recently won the European CE Mark to introduce its Atlas…
Read More » -
Extremities
Moximed Announces CE Mark and First Commercial Use of AtlasTM Knee System
HAYWARD, Calif.–(BUSINESS WIRE)–Moximed®, Inc. announced the CE Mark of the Atlas Knee System, its next-generation knee joint unloader for pre-arthroplasty…
Read More » -
Extremities
Medical device maker Moximed raises funds for knee implant
By Gina Hall Medical device company Moximed raised $33 million in private equity on Thursday to help patients suffering from…
Read More »